Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electrophysiological Remodelling Secondary to Metabolic, Inflammatory and Cardiomyopathic Processes

NCT03910725 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT03910725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03910725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electrophysiological Remodelling Secondary to Metabolic, Inflammatory and Cardiomyopathic Processes
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Unknown status
Start date
November 21, 2019
Completion date
December 31, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmia, cardiomyopathy, dilated, inflammation, obesity, sudden cardiac death